市場調查報告書
商品編碼
1392190
軟骨修復市場 - 按形態(基於細胞、非細胞)、按類型(透明軟骨、纖維軟骨)、按應用(膝關節、髖關節)、按最終用途(醫院和診所、門診手術中心)-全球預測, 2023-2032Cartilage Repair Market - By Modality (Cell Based, Non-cell Based), By Type (Hyaline Cartilage, Fibrocartilage), By Application (Knee, Hip), By End-use (Hospitals and Clinics, Ambulatory Surgical Centers) - Global Forecast, 2023-2032 |
由於運動相關損傷的增加以及隨後對最佳恢復和關節功能的先進解決方案的需求,軟骨修復市場規模預計從 2023 年到 2032 年將以超過 10% 的CAGR擴大。再生醫學和外科技術的不斷進步為運動員提供了創新的干涉措施,以實現持續的表現。對運動相關傷害預防和綜合復健的高度重視進一步推動了軟骨修復療法的採用。
此外,醫療機構、研究機構和產業參與者之間的合作和收購等持續業務策略的跳躍將促進創新軟骨修復解決方案的開發和商業化,推動市場成長。舉個例子,2023 年 11 月,全錄輝收購了 CartiHeal,該公司生產 Agili-C,一種用於膝蓋軟骨再生的尖端運動醫學療法。
軟骨修復產業分為模式、類型、應用、最終用途和區域。
根據類型,纖維軟骨修復市場將在 2022 年產生大量收入,預計 2023 年至 2032 年CAGR將達到 10.4%。關節損傷和退化性疾病盛行率的上升正在刺激有針對性的纖維軟骨修復策略的發展。此外,對解決特定軟骨修復挑戰、提高患者治療效果以及推動更廣泛的骨科再生醫學領域進步的堅定承諾將推動該細分市場的成長。
就最終用途而言,由於微創軟骨修復技術的興起,門診手術中心(ASC)領域的軟骨修復產業預計在 2023 年至 2032 年間實現 10.5% 的成長率。 ASC 為軟骨修復手術提供了方便且經濟高效的設定。此外,對減少住院治療和加快康復時間的需求激增可能會促使患者更傾向於在 ASC 進行軟骨修復治療。
從地區來看,亞太地區軟骨修復市場預計 2023 年至 2032 年CAGR將達到 12.4%。運動相關傷害的增加、人口老化的加劇以及對先進骨科治療意識的不斷增強,都推動了對軟骨修復解決方案的需求。此外,再生醫學和骨科技術的進步正在推動該地區創新軟骨修復療法的採用。
此外,專注於提高軟骨修復材料效率的研究工作的激增可能會增強該地區的行業前景。例如,2023年5月,香港城市大學聯同華潤科技研究院、神州航太生物科技集團進行聯合科學實驗,測試新型軟骨修復材料樣本在外太空的效能。
Cartilage Repair Market size is estimated to expand at over 10% CAGR from 2023-2032, driven by the rise in sports-related injuries along with the subsequent need for advanced solutions for optimal recovery and joint function. Rising advances in regenerative medicine and surgical techniques offer innovative interventions to athletes for sustained performance. The higher emphasis on sports-related injury prevention and comprehensive rehabilitation is further fueling the adoption of cartilage repair therapies.
Moreover, the jump in ongoing business strategies, such as collaborations and acquisitions between healthcare institutions, research organizations, and industry players will facilitate the development and commercialization of innovative cartilage repair solutions, propelling the market growth. To cite an instance, in November 2023, Smith+Nephew acquired CartiHeal, the company producing Agili-C, a cutting-edge sports medicine treatment for knee cartilage regeneration.
The cartilage repair industry is segmented into modality, type, application, end-use, and region.
Based on type, the fibrocartilage repair market generated substantial revenue in 2022 and is projected to hit 10.4% CAGR from 2023-2032. The rising prevalence of joint injuries and degenerative conditions is spurring the development of targeted fibrocartilage repair strategies. Moreover, the strong commitment towards addressing specific cartilage repair challenges, enhancing the patient outcomes, and driving advancements in the broader field of orthopedic regenerative medicine will propel the segment growth.
In terms of end-use, the cartilage repair industry from the ambulatory surgical centers (ASCs) segment is set to witness 10.5% growth rate between 2023 and 2032 owing to the rise in minimally invasive cartilage repair techniques. ASCs offer a convenient and cost-effective setting for cartilage repair procedures. Furthermore, the surging demand for reduced hospitalization and quicker recovery times is likely to fuel the patient preference for cartilage repair treatment at ASCs.
Regionally, the Asia Pacific cartilage repair market is estimated to expand at 12.4% CAGR from 2023-2032. The increasing sports-related injuries, the rising aging population, and the growing awareness of advanced orthopedic treatments is boosting the demand for cartilage repair solutions. Additionally, the higher advancements in regenerative medicine and orthopedic technologies is fueling the adoption of innovative cartilage repair therapies in the region.
Moreover, the surge in research efforts focused on enhancing the efficiency of cartilage repair materials may augment the regional industry outlook. For instance, in May 2023, The City University of Hong Kong joined forces with the China Resources Research Institute of Science and Technology and the Shenzhou Space Biotechnology Group to launch joint scientific experiments to test samples of new cartilage repair materials for effectiveness in the outer space.